This study evaluates an investigational medication for pancreatic ductal adenocarcinoma. This study investigates the effects of an investigational medication compared to standard observation in patients who have had surgery for this condition.
The study will focus on assessing the safety and effectiveness of the investigational medication. Researchers are evaluating how well patients do without any evidence of disease after receiving the investigational medication.
- Who can participate: Adults aged 18 and older who have had surgery for pancreatic ductal adenocarcinoma and completed chemotherapy may be eligible. Participants must have good organ function and be able to take oral medications.
- Study details: Participants in this study will receive either the investigational medication or undergo standard observation. The study will evaluate the effects on disease-free survival. An inactive substance that looks like the investigational medicine but does not contain any medicine may be used in some cases.
How understandable was the trial content above?
Hard to understand
Easy to understand